All Type of News
New product licenses issued last year total 5,188
The Korea Food and Drug Administration said on January 28 it approved a total of 5,188 medicines last year, including oriental medicines and raw materials.
Of the 2,849 pharmaceutical drugs licenses, tonics topped ...
Strategic alliances unavoidable course for domestic and foreign drugmakers
Business sources say that aggressive expansions through strategic alliances among drug manufacturers are inevitable amid rapid globalization of pharmaceutical markets.
Market insiders expect expects local and forei...
Priligy is popular in young people
Priligy (dapoxetine), which is marketed by Janssen Korea, is attracting the keenest attention from people in their 20s and 30s who have suffered premature ejaculation (PE).
Priligy has been prescribed to 70,000 Kor...
CJ to release Japan’s No. 1 painkiller
CJ Corporation said on January 27 that it will launch here Japan based Lion Corporation’s leading analgesic Bufferin tablets – Bufferin Lady and Bufferin Plus within this month.
This antipyretic analgesic formula f...
LG Life Sciences to raise overseas sales to 60%
LG Life Sciences (LGLS) painted a rosy picture for the company’s pharmaceutical business, saying it will increase its overseas sales by 60% in 2015, a company executive said on January 27.
“Biopharmaceutical busine...
Sibutramine preparations to be likely viable
Local manufacturers of sibutramine preparations are waiting for the imminent January 29 decision by the Korea Food and Drug Administration.
Market analysts predict sibutramine preparations will continue to be marke...
International flu symposium to open Jan. 29
The Korea Research Institute of Bioscience and Biotechnology (KRBBA) and the International Vaccine Institute will hold an international symposium on influenza on January 29 to cope with the epidemic influenza.
Abou...
New cGMP system boost competitiveness of local drug makers
With the introduction of a new Good Practice Manufacturing (GMP) system in 2008, Korean pharmaceutical companies are focusing on the manufacture of quality pharmaceuticals, according to the Korea Food and Drug Adminis...
70% back pharmacist’s intervention
A majority of people feel possible about pharmacist’s role to re-use older medicines at home, according to a recent survey.
The survey of 2,070 citizens in Seoul, conducted by Seoul National University, showed that...
Osteoporosis drug plus calcium therapy is negligible, HIRA says
Korean doctors are liable to prescribe osteoporosis drugs, such as bisphonates, without calcium supplements, according to the Health, Insurance Review and Assessment Service (HIRA), an affiliate of the health ministry...
